Evan David Seigerman, BMO head of healthcare research, joins 'Squawk Box' to break down Pfizer and Regeneron's quarter ...

Shares of Bank of Montreal BMO inched 0.57% higher to C$132.47 Monday, in what proved to be an all-around favorable trading ...

To help you narrow down your options, here are the best savings rates and where you’ll find them -- plus some tips from CNET ...

The company’s $3 billion in earnings for the first quarter missed on both top and bottom line, according to BMO Capital ...

Treasury yields held steady Tuesday morning as investors awaited data on consumer confidence and job openings, although the benchmark 10-year yield intermittently fell below a key technical level that ...

BMO senior economist Shelly Kaushik warns that incoming economic data “don’t paint a pretty picture”, ...

Romania has taken first place in the team ranking at the 2025 Balkan Mathematical Olympiad (BMO), held in Sarajevo, Bosnia ...

Canadians voted for Mark Carney to stay on as Prime Minister on Monday, granting his Liberal Party a fourth consecutive ...

On an adjusted basis, Regeneron earned $8.22 per share in the first quarter, below the average analyst estimate of $8.82, ...

Power Finance honorees show how all types of institutions have made a broader variety of offerings the go-to strategy for ...

Pfizer’s R&D organization has been in flux for almost two years now, since the $43 billion acquisition of ADC specialist ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.